Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-19-002468)

Filing Details

Accession Number:: 0001179110-19-002468
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-02-25 10:10:51
Reporting Period:: 2019-02-22

Accepted Time:: 2019-02-25 10:10:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
855654	Immunogen Inc	IMGN	Pharmaceutical Preparations (2834)	042726691

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1691868	Anna Berkenblit	C/O Immunogen, Inc. 830 Winter Street Waltham MA 02152	Vp & Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-02-22	16,562	$5.60	118,662	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Weighted average price of shares sold.
The transaction reported in this Form 4 was made in connection with the satisfaction of the reporting person's tax withholding obligation arising from the vesting of restricted shares and was effected pursuant to a 10b5-1 trading plan executed by the reporting person.